NASDAQ: PMVP
Pmv Pharmaceuticals Inc Stock Ownership - Who owns Pmv Pharmaceuticals?

Insider buying vs selling

Have Pmv Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Henry MacKPresident and CEO2025-10-27220,643$1.37
$302.28kBuy
Orbimed Advisors LLC10% Owner2025-10-231,000,000$1.52
$1.52MSell

1 of 1

PMVP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMVP insiders and whales buy or sell their stock.

PMVP Shareholders

What type of owners hold Pmv Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Arnold L. Oronsky12.10%6,469,911$8.60MInsider
Orbimed Advisors LLC9.52%5,089,330$6.77MInsider
Interwest Partners X LP8.42%4,502,480$5.99MInsider
V. Oncology Scs Sicavsif Nextech4.73%2,528,290$3.36MInsider
Boxer Capital LLC4.36%2,329,073$3.10MInsider
Ra Capital Management LP3.20%1,710,265$2.27MInsider
Thilo Schroeder2.06%1,101,283$1.46MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP1.42%760,267$1.01MInsider
David Henry MacK0.95%508,087$675.76kInsider
Arnold J. Levine0.77%409,842$545.09kInsider

1 of 3

PMVP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMVP0.06%48.83%Net Selling
SPRO0.04%62.43%Net Selling
CING0.01%30.09%Net Buying
OKYO0.00%100.00%Net BuyingNet Buying
KLRS0.01%99.99%Net Buying

Pmv Pharmaceuticals Stock Ownership FAQ

Who owns Pmv Pharmaceuticals?

Pmv Pharmaceuticals (NASDAQ: PMVP) is owned by 0.06% institutional shareholders, 48.83% Pmv Pharmaceuticals insiders, and 51.11% retail investors. Arnold L. Oronsky is the largest individual Pmv Pharmaceuticals shareholder, owning 6.47M shares representing 12.10% of the company. Arnold L. Oronsky's Pmv Pharmaceuticals shares are currently valued at $8.60M.

If you're new to stock investing, here's how to buy Pmv Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.